SlideShare une entreprise Scribd logo
1  sur  52
Télécharger pour lire hors ligne
Working
with Oracle Clinical/RDC:
Flexible Study Design
Steven Rifkin
Welcome and Introduction
Steven Rifkin
Chief Application Expert
• 15+ years of experience with
Oracle Clinical, TMS and RDC;
doing Database Design, Study
Conduct and custom
programming
Today’s Agenda
Time Topic
10:00-10:05 Welcome and Introduction
10:05-10:10 Who, What and Why?
10:10-10:30 Flexible Study Design Discussion
and Demonstrations
10:30-10:45 Flexible Study Setup
10:45-10:55 Q&A
10:55-11:00 Wrap-up and Contact Information
Who, What and Why?
• Who is the intended audience?
– Current OC/RDC users contemplating an upgrade
to version 4.6
– New users of OC/RDC 4.6 who want to learn
more about flexible study design
– Non-OC/RDC users evaluating the features of the
application who perhaps previously reviewed an
earlier OC/RDC version
Who, What and Why?
• What features are we examining today?
– Demonstrate a flexible study showing ability to
enable or disable entire forms or visits based on
data responses
– Setting up a Flexible Study via an Enhanced DCI
Book
Who, What and Why?
• Why are these features important?
– Organizations need the ability to create a study
schedule which is flexible for more complex
clinical trials
– Especially important when the sites will perform
the entry in an EDC system so that users are
presented only with the forms/visits they need
Flexible Study Design …
• Prior to Release 4.6, Oracle Clinical required
strict sequential navigation through a set of
Clinical Planned Events in a DCI book
• Some trials require complex (or flexible)
studies with multiple treatment arms with
different patient groups receiving different
assessments
– Common for Oncology trials
Flexible Study Design
• Release 4.6 allows multiple pathways to be
defined in a single DCI Book using
conditional logic based on data for a specific
patient
– Logic will make a new set of visits and CRFs
expected for the patient
• The RDC Onsite interface now has a
dynamic display of newly expected visit and
CRF data as patient data is entered
Example Study
Screening Completion
A:Cycle 2 A:Cycle 3A:Cycle 1
B:Cycle 2B:Cycle 1
Logs
Treatment 1
Treatment 2 Treatment 3
Interim
Treatment 1 Treatment 2
Treatment 3 Interim
Treatment 4
Arm A
Arm B
Rules for Example Study
1. Until any data for Demography form is entered, only
the Screening Visit is expected; after demography
data, the Completion and AE Log visits are expected
2. The Enrollment CRF during the screening Visit will
determine and schedule the Cycle 1 visits in either
Arm A or Arm B
3. Response to a question during Interim Visit in a cycle
with schedule next cycle or end the study for subject
4. If treatment not given during any treatment visit,
subject will leave the study
5. If treatment is given, a new expected form is added
for the visit
Example Study: Rule 1
Screening Completion
A:Cycle 2 A:Cycle 3A:Cycle 1
B:Cycle 2B:Cycle 1
Logs
Treatment 1
Treatment 2 Treatment 3
Interim
Treatment 1 Treatment 2
Treatment 3 Interim
Treatment 4
Arm A
Arm B
Only the Screening Visit is expected until data entered on the Demography
form. Demog entry will enable the Completion Visit and the AE Log
Flexible Study Design
Demonstration
Example Study: Rule 2
Screening Completion
A:Cycle 2 A:Cycle 3A:Cycle 1
B:Cycle 2B:Cycle 1
Logs
Treatment 1
Treatment 2 Treatment 3
Interim
Treatment 1 Treatment 2
Treatment 3 Interim
Treatment 4
Arm A
Arm B
Enrollment CRF specifies if Patient is in Arm A or Arm B and schedules cycle 1 treatments
Flexible Study Design
Demonstration
Example Study: Rule 3
Screening Completion
A:Cycle 2 A:Cycle 3A:Cycle 1
B:Cycle 2B:Cycle 1
Logs
Treatment 1
Treatment 2 Treatment 3
Interim
Treatment 1 Treatment 2
Treatment 3 Interim
Treatment 4
Arm A
Arm B
YES to “continue to next cycle” in any Interim Visit will schedule the next Treatment Cycle
NO to “continue to next cycle” in any Interim Visit bypass remaining cycles
Flexible Study Design
Demonstration
Example Study: Rule 4
Screening Completion
A:Cycle 2 A:Cycle 3A:Cycle 1
B:Cycle 2B:Cycle 1
Logs
Treatment 1
Treatment 2 Treatment 3
Interim
Treatment 1 Treatment 2
Treatment 3 Interim
Treatment 4
Arm A
Arm B
NO to “give treatment” in any treatment will bypass remaining visits and cycles
Flexible Study Design
Demonstration
Example Study: Rule 5
YES to “should drug be given” in any treatment will
schedule a new form to be completed at the visit
HEMATOLOGY FORM
Should Drug be given?
Yes
INFUSION FORM
Flexible Study Design
Demonstration
Setup of a Flexible Study
1. Identify the Study as Flexible during initial
study setup to set the Clinical Study State
2. Define Intervals and Clinical Planned
Events for the study
3. Set up “Enhanced” DCI Book with DCI
Book Rules
Creating a Flexible Study
Conduct  Security  Clinical Study States
Intervals
• An Interval is a time span in which there are one or more visits
(Clinical Planned Events)
• Types of Intervals
– Phase
– Periods
– Sub-periods
Modeling the study will involve placing visits in specific Intervals
• Need to plan since visits in an interval will be enabled by logic in Flex
Study Design
Phase
Period
Sub-Period
Intervals
Modeling Intervals
Periods
Treatment
Phase
Completion
Phase
Screening
Phase
Logs
Phases
Sub-periods
Arm A Arm B
A: Cycle 1 A: Cycle 3A: Cycle 2 B: Cycle 1 B: Cycle 2
indicate intervals where visits (CPEs) will be placed
Each Interval must have a unique name
Defining Intervals
Intervals are defined from the Easy Study Design Screen
Design  Studies  Easy Study Design
Defining Clinical Planned Events …
• Each Clinical Planned Event used in your study must be
defined and associated with an Interval (Phase, Period or
Sub-period)
• Each CPE in the study must have a unique name – use a
shorthand to indicate parent phase, period and sub-period
– Treatment 1 visit is defined in multiple intervals
• Visit for Treatment Phase, Arm A, Cycle 1 named AC1 TREATMENT 1
• Visit for Treatment Phase, Arm A, Cycle 2 named AC2 TREATMENT 1
• Visit for Treatment Phase, Arm B, Cycle 1 named BC1 TREATMENT 1
• Visit No. field reflects the sequence in the schedule and will
not reflect the actual sequence of events for a patient
• Duration fields are required but have no effect on the flexible
study definition
Enhanced DCI Books …
• Function for Enhanced DCI Books has four
sections
– Navigator: Display screen listing the visits
defined for the study and the interval to which
each is assigned
– Constraints: Limit the unplanned use of specific
DCIs (no change from earlier versions)
– Interval Rules: Define when an interval and its
associated visits and DCIs will become expected
– DCI Rules: Define when a specific DCI becomes
expected in a visit or over all visits
27
Enhanced DCI Books
Definition  DCIs  Enhanced DCI Books
Buttons will be disabled for non-flexible studies
Enhanced DCI Books: Navigator …
Definition  DCIs  Enhanced DCI Books, [Navigator]
This column will be blank
for non-flexible studies
Select a Visit and click [DCI Book Pages for CPE]
to define which DCIs are expected for that Visit
Counts will update
dynamically as DCIs are
added to Visits and
Rules defined
CPE and Intervals are
pre-populated with
Events for the Study
Enhanced DCI Books: Navigator …
Definition  DCIs  Enhanced DCI Books, [Navigator], [DCI Book Pages for CPE]
Enter (or select with LOV) a DCI that may be
expected at this Visit
Use the buttons to
change the Visit to
which DCIs will be
assigned
Enhanced DCI Books: Rules
• Book Rules are available only for Flexible Studies
• Rules apply to all patients to which the book is
assigned
• Interval Rules enable an interval and the visits
within the intervals
• DCI Rules enable a specific DCI
– DCI within the current visit
or
– DCI across all visits in which the DCI is defined
• Rules determine “expectedness”
Enhanced DCI Books:
Interval Rules
• All Intervals are considered enabled unless a target
of an Interval Rule
• Interval Rules are specified for a specific DCI
– will apply to all visits where the DCI is entered
• Triggers at a DCI determine if an interval is
enabled
– Trigger Conditions
• Trigger an interval when any data is entered in the DCI
• Trigger an interval when there is a specified response to a
question
– Trigger Actions
• Enable one or more named target intervals
• Enable Next Interval
• Bypass to a specified target interval
Enhanced DCI Books: Rules
Prior to definition of any Book Rules all DCIs in all
CPEs in all intervals will appear in the RDC surround
Enhanced DCI Books:
Interval Rules …
Definitions  DCIs  Enhanced DCI Books, [Interval Rules]
RULE: Enable the Completion and Logs Intervals if any data is entered on Demography
Enhanced DCI Books:
Interval Rules …
Before Demography Entered:
Completion and Logs Intervals
do not appear -- they are now
Targets of Rules
Enhanced DCI Books:
Interval Rules …
After Demography Entered:
Completion and Logs Intervals
appear -- the Interval Rule
enables them
Treatment intervals still appear
because these are not yet targets
of an interval rule!
Enhanced DCI Books:
Interval Rules …
Definitions  DCIs  Enhanced DCI Books, [Interval Rules]
RULE: enable the “A Cycle 1” Interval or the “B Cycle 1” Interval dependent
on the Arm assigned on Enrollment DCI
Enhanced DCI Books:
Interval Rules …
Before Enrollment DCI is completed, no visits in either the “A Cycle 1” Interval or
the “B Cycle 1” Interval will be present because both intervals are now targets
Enhanced DCI Books:
Interval Rules …
When Enrollment DCI is completed, the visits in either the “A Cycle 1” Interval or
the “B Cycle 1” Interval will be added as enabled
Enrolled in A Arm
Enhanced DCI Books:
Interval Rules …
RULE: At last (INTERIM) visit for any cycle, if response to the NEXT_CYCLE_YN
question is NO, bypass to the COMPLETION Interval; if response is YES, then
enable the next sequential interval
Enhanced DCI Books:
Interval Rules …
Without DEMOGRAPHY, only Screening Interval is enabled since use of [Next Interval] at
the end of all cycles makes each treatment cycle a target of a rule
Enhanced DCI Books:
Interval Rules …
With DEMOGRAPHY, Completion and Logs Intervals are enabled
Enhanced DCI Books:
Interval Rules …
If Enrolled in Arm A, Cycle 1 for Arm A enabled
Enhanced DCI Books:
Interval Rules …
At INTERIM Visit for Arm A Cycle 1, specify YES to continue to next cycle --
and Arm A Cycle 2 Visits are enabled
Enhanced DCI Books:
Interval Rules …
At INTERIM Visit for Arm A Cycle 1, specify NO to continue to next cycle --
and Arm A Cycle 2 Visits are not enabled: bypassed other cycles
Enhanced DCI Books:
Interval Rules …
At INTERIM Visit for Cycle 2, specify YES to continue to next cycle --
and Arm A Cycle 3 Visits are enabled
Enhanced DCI Books:
Interval Rules
At AC1 Treatment 2, Dose was not given. Only Visits in the Completion and Logs
Intervals are enabled; Visits after the current visit in the current interval are disabled!
Enhanced DCI Books:
DCI Rules …
• Within an Interval, rules can be defined to
enable specific DCIs in the visit or across all
visits which contain that DCI
– Only DCIs which contain one or more questions
associated with a DVG can be have DCI rules
Enhanced DCI Books:
DCI Rules …
RULE: At a Treatment Visit, if the Dose is given (GIVE_DOSE_YN=YES) then an
infusion form must be made “expected” in that visit
Enhanced DCI Books:
DCI Rules
Before GIVE_DOSE_YN was completed,
no INFUSION form expected at visit
After GIVE_DOSE_YN was completed, an
INFUSION form is expected at visit!
Q&A
Closing
Thank you for attending!
This webinar will be posted on
www.biopharm.com
within 24 hours
Contact BioPharm
United States: +1 877 654 0033
United Kingdom: +44 (0) 1865 910200
Email Address: info@biopharm.com

Contenu connexe

En vedette

Argus Event Tab Screen - Katalyst HLS
Argus Event Tab Screen - Katalyst HLSArgus Event Tab Screen - Katalyst HLS
Argus Event Tab Screen - Katalyst HLSKatalyst HLS
 
MedDRA Coding - Katalyst HLS
MedDRA Coding - Katalyst HLSMedDRA Coding - Katalyst HLS
MedDRA Coding - Katalyst HLSKatalyst HLS
 
Expectedness/Unexpectedness Assessment_Katalyst HLS
Expectedness/Unexpectedness Assessment_Katalyst HLSExpectedness/Unexpectedness Assessment_Katalyst HLS
Expectedness/Unexpectedness Assessment_Katalyst HLSKatalyst HLS
 
Protocol Understanding_ Clinical Data Management_KatalystHLS
Protocol Understanding_ Clinical Data Management_KatalystHLSProtocol Understanding_ Clinical Data Management_KatalystHLS
Protocol Understanding_ Clinical Data Management_KatalystHLSKatalyst HLS
 
Clinical Data Management Process Overview_Katalyst HLS
Clinical Data Management Process Overview_Katalyst HLSClinical Data Management Process Overview_Katalyst HLS
Clinical Data Management Process Overview_Katalyst HLSKatalyst HLS
 
Clinical data management
Clinical data managementClinical data management
Clinical data managementUpendra Agarwal
 
Clinical Data Management
Clinical Data ManagementClinical Data Management
Clinical Data ManagementShray Jali
 
Clinical Data Management
Clinical Data ManagementClinical Data Management
Clinical Data Managementbiinoida
 
Programmatic Load of the Oracle Clinical Global Library
Programmatic Load of the Oracle Clinical Global LibraryProgrammatic Load of the Oracle Clinical Global Library
Programmatic Load of the Oracle Clinical Global LibraryPerficient
 
Effect of Procedure Question Group Attributes on Performance of Batch Validation
Effect of Procedure Question Group Attributes on Performance of Batch ValidationEffect of Procedure Question Group Attributes on Performance of Batch Validation
Effect of Procedure Question Group Attributes on Performance of Batch ValidationPerficient
 
Inside an Oracle Clinical Validation Procedure
Inside an Oracle Clinical Validation ProcedureInside an Oracle Clinical Validation Procedure
Inside an Oracle Clinical Validation ProcedurePerficient
 
From Rocket Science to Data Science
From Rocket Science to Data ScienceFrom Rocket Science to Data Science
From Rocket Science to Data ScienceSanghamitra Deb
 
Malcolm Pradhan on Pathology in Clincial Decision Support and the role of Dee...
Malcolm Pradhan on Pathology in Clincial Decision Support and the role of Dee...Malcolm Pradhan on Pathology in Clincial Decision Support and the role of Dee...
Malcolm Pradhan on Pathology in Clincial Decision Support and the role of Dee...Cirdan
 
Using Machine Learning to Automate Clinical Pathways
Using Machine Learning to Automate Clinical PathwaysUsing Machine Learning to Automate Clinical Pathways
Using Machine Learning to Automate Clinical Pathwaysdiannepatricia
 
Clinical Trial Management Systems of next next decade
Clinical Trial Management Systems of next next decadeClinical Trial Management Systems of next next decade
Clinical Trial Management Systems of next next decadeFotis Stathopoulos
 
Oncology Big Data: A Mirage or Oasis of Clinical Value?
Oncology Big Data:  A Mirage or Oasis of Clinical Value? Oncology Big Data:  A Mirage or Oasis of Clinical Value?
Oncology Big Data: A Mirage or Oasis of Clinical Value? Michael Peters
 

En vedette (17)

Argus Event Tab Screen - Katalyst HLS
Argus Event Tab Screen - Katalyst HLSArgus Event Tab Screen - Katalyst HLS
Argus Event Tab Screen - Katalyst HLS
 
MedDRA Coding - Katalyst HLS
MedDRA Coding - Katalyst HLSMedDRA Coding - Katalyst HLS
MedDRA Coding - Katalyst HLS
 
Expectedness/Unexpectedness Assessment_Katalyst HLS
Expectedness/Unexpectedness Assessment_Katalyst HLSExpectedness/Unexpectedness Assessment_Katalyst HLS
Expectedness/Unexpectedness Assessment_Katalyst HLS
 
Protocol Understanding_ Clinical Data Management_KatalystHLS
Protocol Understanding_ Clinical Data Management_KatalystHLSProtocol Understanding_ Clinical Data Management_KatalystHLS
Protocol Understanding_ Clinical Data Management_KatalystHLS
 
Clinical Data Management Process Overview_Katalyst HLS
Clinical Data Management Process Overview_Katalyst HLSClinical Data Management Process Overview_Katalyst HLS
Clinical Data Management Process Overview_Katalyst HLS
 
Clinical data management
Clinical data managementClinical data management
Clinical data management
 
Clinical Data Management
Clinical Data ManagementClinical Data Management
Clinical Data Management
 
Clinical Data Management
Clinical Data ManagementClinical Data Management
Clinical Data Management
 
Programmatic Load of the Oracle Clinical Global Library
Programmatic Load of the Oracle Clinical Global LibraryProgrammatic Load of the Oracle Clinical Global Library
Programmatic Load of the Oracle Clinical Global Library
 
Effect of Procedure Question Group Attributes on Performance of Batch Validation
Effect of Procedure Question Group Attributes on Performance of Batch ValidationEffect of Procedure Question Group Attributes on Performance of Batch Validation
Effect of Procedure Question Group Attributes on Performance of Batch Validation
 
Inside an Oracle Clinical Validation Procedure
Inside an Oracle Clinical Validation ProcedureInside an Oracle Clinical Validation Procedure
Inside an Oracle Clinical Validation Procedure
 
Data day2017
Data day2017Data day2017
Data day2017
 
From Rocket Science to Data Science
From Rocket Science to Data ScienceFrom Rocket Science to Data Science
From Rocket Science to Data Science
 
Malcolm Pradhan on Pathology in Clincial Decision Support and the role of Dee...
Malcolm Pradhan on Pathology in Clincial Decision Support and the role of Dee...Malcolm Pradhan on Pathology in Clincial Decision Support and the role of Dee...
Malcolm Pradhan on Pathology in Clincial Decision Support and the role of Dee...
 
Using Machine Learning to Automate Clinical Pathways
Using Machine Learning to Automate Clinical PathwaysUsing Machine Learning to Automate Clinical Pathways
Using Machine Learning to Automate Clinical Pathways
 
Clinical Trial Management Systems of next next decade
Clinical Trial Management Systems of next next decadeClinical Trial Management Systems of next next decade
Clinical Trial Management Systems of next next decade
 
Oncology Big Data: A Mirage or Oasis of Clinical Value?
Oncology Big Data:  A Mirage or Oasis of Clinical Value? Oncology Big Data:  A Mirage or Oasis of Clinical Value?
Oncology Big Data: A Mirage or Oasis of Clinical Value?
 

Similaire à Flexible Study Design in Oracle Clinical and Remote Data Capture 4.6

Making Oracle Clinical and Remote Data Capture 4.6 Features Work for You
Making Oracle Clinical and Remote Data Capture 4.6 Features Work for YouMaking Oracle Clinical and Remote Data Capture 4.6 Features Work for You
Making Oracle Clinical and Remote Data Capture 4.6 Features Work for YouPerficient
 
PICI’s Best Practices for Building Oncology Studies in an EDC
PICI’s Best Practices for Building Oncology Studies in an EDCPICI’s Best Practices for Building Oncology Studies in an EDC
PICI’s Best Practices for Building Oncology Studies in an EDCVeeva Systems
 
6_Kimberly Todd - QA and QC.pptx
6_Kimberly Todd - QA and QC.pptx6_Kimberly Todd - QA and QC.pptx
6_Kimberly Todd - QA and QC.pptxJoiGirish1
 
DIRECT CARE PROJECT PART 1ASSESSMENT AND DIAGNOSISDirectio
DIRECT CARE PROJECT PART 1ASSESSMENT AND DIAGNOSISDirectioDIRECT CARE PROJECT PART 1ASSESSMENT AND DIAGNOSISDirectio
DIRECT CARE PROJECT PART 1ASSESSMENT AND DIAGNOSISDirectioAlyciaGold776
 
Individual Success PlanCourse # DNP 830Target Practice Hours.docx
Individual Success PlanCourse # DNP 830Target Practice Hours.docxIndividual Success PlanCourse # DNP 830Target Practice Hours.docx
Individual Success PlanCourse # DNP 830Target Practice Hours.docxcarliotwaycave
 
UPHC QUALITY MANAGEMENT
UPHC QUALITY MANAGEMENTUPHC QUALITY MANAGEMENT
UPHC QUALITY MANAGEMENTLincy Margaret
 
122 Part 1 - GuideFigure 4-15. Close Project or Phase Dat.docx
122 Part 1 - GuideFigure 4-15. Close Project or Phase Dat.docx122 Part 1 - GuideFigure 4-15. Close Project or Phase Dat.docx
122 Part 1 - GuideFigure 4-15. Close Project or Phase Dat.docxaulasnilda
 
Course Project Hospital Data Analysis and ReportingObjectiveThe
Course Project Hospital Data Analysis and ReportingObjectiveTheCourse Project Hospital Data Analysis and ReportingObjectiveThe
Course Project Hospital Data Analysis and ReportingObjectiveTheCruzIbarra161
 
Process Improvement Plan For this, your penultimate assignment .docx
Process Improvement Plan For this, your penultimate assignment .docxProcess Improvement Plan For this, your penultimate assignment .docx
Process Improvement Plan For this, your penultimate assignment .docxstilliegeorgiana
 
Entrprise Services Planning
Entrprise Services PlanningEntrprise Services Planning
Entrprise Services PlanningRenee Troughton
 
7-1. curriculum assessments recruitment QI Emma Vaux
7-1. curriculum assessments recruitment QI Emma Vaux7-1. curriculum assessments recruitment QI Emma Vaux
7-1. curriculum assessments recruitment QI Emma VauxSandeep Dutta
 
ONC 2015 Edition EHR Certification Criteria
ONC 2015 Edition EHR Certification CriteriaONC 2015 Edition EHR Certification Criteria
ONC 2015 Edition EHR Certification CriteriaBrian Ahier
 
Overview
OverviewOverview
Overview225XX
 
Defining the New MCC Blueprint
Defining the New MCC Blueprint Defining the New MCC Blueprint
Defining the New MCC Blueprint MedCouncilCan
 
Development of Cochrane Response part 1
Development of Cochrane Response part 1Development of Cochrane Response part 1
Development of Cochrane Response part 1Juliane Ried
 
Programming Gym-based sessions L3
Programming Gym-based sessions L3Programming Gym-based sessions L3
Programming Gym-based sessions L3heather13mcfarlane
 

Similaire à Flexible Study Design in Oracle Clinical and Remote Data Capture 4.6 (20)

Making Oracle Clinical and Remote Data Capture 4.6 Features Work for You
Making Oracle Clinical and Remote Data Capture 4.6 Features Work for YouMaking Oracle Clinical and Remote Data Capture 4.6 Features Work for You
Making Oracle Clinical and Remote Data Capture 4.6 Features Work for You
 
PICI’s Best Practices for Building Oncology Studies in an EDC
PICI’s Best Practices for Building Oncology Studies in an EDCPICI’s Best Practices for Building Oncology Studies in an EDC
PICI’s Best Practices for Building Oncology Studies in an EDC
 
6_Kimberly Todd - QA and QC.pptx
6_Kimberly Todd - QA and QC.pptx6_Kimberly Todd - QA and QC.pptx
6_Kimberly Todd - QA and QC.pptx
 
DIRECT CARE PROJECT PART 1ASSESSMENT AND DIAGNOSISDirectio
DIRECT CARE PROJECT PART 1ASSESSMENT AND DIAGNOSISDirectioDIRECT CARE PROJECT PART 1ASSESSMENT AND DIAGNOSISDirectio
DIRECT CARE PROJECT PART 1ASSESSMENT AND DIAGNOSISDirectio
 
Individual Success PlanCourse # DNP 830Target Practice Hours.docx
Individual Success PlanCourse # DNP 830Target Practice Hours.docxIndividual Success PlanCourse # DNP 830Target Practice Hours.docx
Individual Success PlanCourse # DNP 830Target Practice Hours.docx
 
UPHC QUALITY MANAGEMENT
UPHC QUALITY MANAGEMENTUPHC QUALITY MANAGEMENT
UPHC QUALITY MANAGEMENT
 
122 Part 1 - GuideFigure 4-15. Close Project or Phase Dat.docx
122 Part 1 - GuideFigure 4-15. Close Project or Phase Dat.docx122 Part 1 - GuideFigure 4-15. Close Project or Phase Dat.docx
122 Part 1 - GuideFigure 4-15. Close Project or Phase Dat.docx
 
PDCA Cycle
PDCA CyclePDCA Cycle
PDCA Cycle
 
Course Project Hospital Data Analysis and ReportingObjectiveThe
Course Project Hospital Data Analysis and ReportingObjectiveTheCourse Project Hospital Data Analysis and ReportingObjectiveThe
Course Project Hospital Data Analysis and ReportingObjectiveThe
 
Process Improvement Plan For this, your penultimate assignment .docx
Process Improvement Plan For this, your penultimate assignment .docxProcess Improvement Plan For this, your penultimate assignment .docx
Process Improvement Plan For this, your penultimate assignment .docx
 
Engaging Public and Patient Partners in Rapid Reviews
Engaging Public and Patient Partners in Rapid ReviewsEngaging Public and Patient Partners in Rapid Reviews
Engaging Public and Patient Partners in Rapid Reviews
 
Entrprise Services Planning
Entrprise Services PlanningEntrprise Services Planning
Entrprise Services Planning
 
7-1. curriculum assessments recruitment QI Emma Vaux
7-1. curriculum assessments recruitment QI Emma Vaux7-1. curriculum assessments recruitment QI Emma Vaux
7-1. curriculum assessments recruitment QI Emma Vaux
 
ONC 2015 Edition EHR Certification Criteria
ONC 2015 Edition EHR Certification CriteriaONC 2015 Edition EHR Certification Criteria
ONC 2015 Edition EHR Certification Criteria
 
Overview
OverviewOverview
Overview
 
Defining the New MCC Blueprint
Defining the New MCC Blueprint Defining the New MCC Blueprint
Defining the New MCC Blueprint
 
Development of Cochrane Response part 1
Development of Cochrane Response part 1Development of Cochrane Response part 1
Development of Cochrane Response part 1
 
programming-pt-with-clients
programming-pt-with-clientsprogramming-pt-with-clients
programming-pt-with-clients
 
Programming Gym-based sessions L3
Programming Gym-based sessions L3Programming Gym-based sessions L3
Programming Gym-based sessions L3
 
086 pcda problemsolving training
086 pcda problemsolving training086 pcda problemsolving training
086 pcda problemsolving training
 

Plus de Perficient

Freedom and Flexibility with Siebel Clinical (CTMS) Open UI
Freedom and Flexibility with Siebel Clinical (CTMS) Open UIFreedom and Flexibility with Siebel Clinical (CTMS) Open UI
Freedom and Flexibility with Siebel Clinical (CTMS) Open UIPerficient
 
Managing Global Studies with Oracle's Siebel Clinical Trial Management System...
Managing Global Studies with Oracle's Siebel Clinical Trial Management System...Managing Global Studies with Oracle's Siebel Clinical Trial Management System...
Managing Global Studies with Oracle's Siebel Clinical Trial Management System...Perficient
 
How to Rapidly Configure Oracle Life Sciences Data Hub (LSH) to Support the M...
How to Rapidly Configure Oracle Life Sciences Data Hub (LSH) to Support the M...How to Rapidly Configure Oracle Life Sciences Data Hub (LSH) to Support the M...
How to Rapidly Configure Oracle Life Sciences Data Hub (LSH) to Support the M...Perficient
 
Cloud-based vs. On-site CTMS - Which is Right for Your Organization?
Cloud-based vs. On-site CTMS - Which is Right for Your Organization?Cloud-based vs. On-site CTMS - Which is Right for Your Organization?
Cloud-based vs. On-site CTMS - Which is Right for Your Organization?Perficient
 
Clinical Trial Supply Management with Siebel CTMS
Clinical Trial Supply Management with Siebel CTMSClinical Trial Supply Management with Siebel CTMS
Clinical Trial Supply Management with Siebel CTMSPerficient
 
Using Oracle Health Sciences Data Management Workbench to Optimize the Manage...
Using Oracle Health Sciences Data Management Workbench to Optimize the Manage...Using Oracle Health Sciences Data Management Workbench to Optimize the Manage...
Using Oracle Health Sciences Data Management Workbench to Optimize the Manage...Perficient
 
Integrating Oracle Argus Safety with other Clinical Systems Using Argus Inter...
Integrating Oracle Argus Safety with other Clinical Systems Using Argus Inter...Integrating Oracle Argus Safety with other Clinical Systems Using Argus Inter...
Integrating Oracle Argus Safety with other Clinical Systems Using Argus Inter...Perficient
 
How St. Jude Medical Manages Oracle Clinical Studies Using Accel-Copy
How St. Jude Medical Manages Oracle Clinical Studies Using Accel-CopyHow St. Jude Medical Manages Oracle Clinical Studies Using Accel-Copy
How St. Jude Medical Manages Oracle Clinical Studies Using Accel-CopyPerficient
 
Evaluating and Investigating Drug Safety Signals with Public Databases
Evaluating and Investigating Drug Safety Signals with Public DatabasesEvaluating and Investigating Drug Safety Signals with Public Databases
Evaluating and Investigating Drug Safety Signals with Public DatabasesPerficient
 
Plug & Play: Benefits of Out-of-the-Box Clinical Development Analytics (CDA) ...
Plug & Play: Benefits of Out-of-the-Box Clinical Development Analytics (CDA) ...Plug & Play: Benefits of Out-of-the-Box Clinical Development Analytics (CDA) ...
Plug & Play: Benefits of Out-of-the-Box Clinical Development Analytics (CDA) ...Perficient
 
The Perils of Clinical Trial Budgeting
The Perils of Clinical Trial BudgetingThe Perils of Clinical Trial Budgeting
The Perils of Clinical Trial BudgetingPerficient
 
2013 OHSUG - Use Cases for using the Program Type View in Oracle Life Science...
2013 OHSUG - Use Cases for using the Program Type View in Oracle Life Science...2013 OHSUG - Use Cases for using the Program Type View in Oracle Life Science...
2013 OHSUG - Use Cases for using the Program Type View in Oracle Life Science...Perficient
 
2013 OHSUG - The Ins and Outs of CTMS Data Migration
2013 OHSUG - The Ins and Outs of CTMS Data Migration2013 OHSUG - The Ins and Outs of CTMS Data Migration
2013 OHSUG - The Ins and Outs of CTMS Data MigrationPerficient
 
2013 OHSUG - Siebel Clinical Integration with Other Systems
2013 OHSUG - Siebel Clinical Integration with Other Systems2013 OHSUG - Siebel Clinical Integration with Other Systems
2013 OHSUG - Siebel Clinical Integration with Other SystemsPerficient
 
2013 OHSUG - Sharing CTMS Data between Sponsors and Contract Research Organiz...
2013 OHSUG - Sharing CTMS Data between Sponsors and Contract Research Organiz...2013 OHSUG - Sharing CTMS Data between Sponsors and Contract Research Organiz...
2013 OHSUG - Sharing CTMS Data between Sponsors and Contract Research Organiz...Perficient
 
2013 OHSUG - Merging Multiple Drug Safety and Pharmacovigilance Databases int...
2013 OHSUG - Merging Multiple Drug Safety and Pharmacovigilance Databases int...2013 OHSUG - Merging Multiple Drug Safety and Pharmacovigilance Databases int...
2013 OHSUG - Merging Multiple Drug Safety and Pharmacovigilance Databases int...Perficient
 
2013 OHSUG - Integration of Argus and Other Products Using the E2B Interchange
2013 OHSUG - Integration of Argus and Other Products Using the E2B Interchange2013 OHSUG - Integration of Argus and Other Products Using the E2B Interchange
2013 OHSUG - Integration of Argus and Other Products Using the E2B InterchangePerficient
 
2013 OHSUG - Use Cases for Using the Program Type View in Oracle Life Science...
2013 OHSUG - Use Cases for Using the Program Type View in Oracle Life Science...2013 OHSUG - Use Cases for Using the Program Type View in Oracle Life Science...
2013 OHSUG - Use Cases for Using the Program Type View in Oracle Life Science...Perficient
 
2013 OHSUG - Facilitating Pharmacovigilance Globalization with Process Reengi...
2013 OHSUG - Facilitating Pharmacovigilance Globalization with Process Reengi...2013 OHSUG - Facilitating Pharmacovigilance Globalization with Process Reengi...
2013 OHSUG - Facilitating Pharmacovigilance Globalization with Process Reengi...Perficient
 
2013 OHSUG - Clinical Data Warehouse Implementation
2013 OHSUG - Clinical Data Warehouse Implementation2013 OHSUG - Clinical Data Warehouse Implementation
2013 OHSUG - Clinical Data Warehouse ImplementationPerficient
 

Plus de Perficient (20)

Freedom and Flexibility with Siebel Clinical (CTMS) Open UI
Freedom and Flexibility with Siebel Clinical (CTMS) Open UIFreedom and Flexibility with Siebel Clinical (CTMS) Open UI
Freedom and Flexibility with Siebel Clinical (CTMS) Open UI
 
Managing Global Studies with Oracle's Siebel Clinical Trial Management System...
Managing Global Studies with Oracle's Siebel Clinical Trial Management System...Managing Global Studies with Oracle's Siebel Clinical Trial Management System...
Managing Global Studies with Oracle's Siebel Clinical Trial Management System...
 
How to Rapidly Configure Oracle Life Sciences Data Hub (LSH) to Support the M...
How to Rapidly Configure Oracle Life Sciences Data Hub (LSH) to Support the M...How to Rapidly Configure Oracle Life Sciences Data Hub (LSH) to Support the M...
How to Rapidly Configure Oracle Life Sciences Data Hub (LSH) to Support the M...
 
Cloud-based vs. On-site CTMS - Which is Right for Your Organization?
Cloud-based vs. On-site CTMS - Which is Right for Your Organization?Cloud-based vs. On-site CTMS - Which is Right for Your Organization?
Cloud-based vs. On-site CTMS - Which is Right for Your Organization?
 
Clinical Trial Supply Management with Siebel CTMS
Clinical Trial Supply Management with Siebel CTMSClinical Trial Supply Management with Siebel CTMS
Clinical Trial Supply Management with Siebel CTMS
 
Using Oracle Health Sciences Data Management Workbench to Optimize the Manage...
Using Oracle Health Sciences Data Management Workbench to Optimize the Manage...Using Oracle Health Sciences Data Management Workbench to Optimize the Manage...
Using Oracle Health Sciences Data Management Workbench to Optimize the Manage...
 
Integrating Oracle Argus Safety with other Clinical Systems Using Argus Inter...
Integrating Oracle Argus Safety with other Clinical Systems Using Argus Inter...Integrating Oracle Argus Safety with other Clinical Systems Using Argus Inter...
Integrating Oracle Argus Safety with other Clinical Systems Using Argus Inter...
 
How St. Jude Medical Manages Oracle Clinical Studies Using Accel-Copy
How St. Jude Medical Manages Oracle Clinical Studies Using Accel-CopyHow St. Jude Medical Manages Oracle Clinical Studies Using Accel-Copy
How St. Jude Medical Manages Oracle Clinical Studies Using Accel-Copy
 
Evaluating and Investigating Drug Safety Signals with Public Databases
Evaluating and Investigating Drug Safety Signals with Public DatabasesEvaluating and Investigating Drug Safety Signals with Public Databases
Evaluating and Investigating Drug Safety Signals with Public Databases
 
Plug & Play: Benefits of Out-of-the-Box Clinical Development Analytics (CDA) ...
Plug & Play: Benefits of Out-of-the-Box Clinical Development Analytics (CDA) ...Plug & Play: Benefits of Out-of-the-Box Clinical Development Analytics (CDA) ...
Plug & Play: Benefits of Out-of-the-Box Clinical Development Analytics (CDA) ...
 
The Perils of Clinical Trial Budgeting
The Perils of Clinical Trial BudgetingThe Perils of Clinical Trial Budgeting
The Perils of Clinical Trial Budgeting
 
2013 OHSUG - Use Cases for using the Program Type View in Oracle Life Science...
2013 OHSUG - Use Cases for using the Program Type View in Oracle Life Science...2013 OHSUG - Use Cases for using the Program Type View in Oracle Life Science...
2013 OHSUG - Use Cases for using the Program Type View in Oracle Life Science...
 
2013 OHSUG - The Ins and Outs of CTMS Data Migration
2013 OHSUG - The Ins and Outs of CTMS Data Migration2013 OHSUG - The Ins and Outs of CTMS Data Migration
2013 OHSUG - The Ins and Outs of CTMS Data Migration
 
2013 OHSUG - Siebel Clinical Integration with Other Systems
2013 OHSUG - Siebel Clinical Integration with Other Systems2013 OHSUG - Siebel Clinical Integration with Other Systems
2013 OHSUG - Siebel Clinical Integration with Other Systems
 
2013 OHSUG - Sharing CTMS Data between Sponsors and Contract Research Organiz...
2013 OHSUG - Sharing CTMS Data between Sponsors and Contract Research Organiz...2013 OHSUG - Sharing CTMS Data between Sponsors and Contract Research Organiz...
2013 OHSUG - Sharing CTMS Data between Sponsors and Contract Research Organiz...
 
2013 OHSUG - Merging Multiple Drug Safety and Pharmacovigilance Databases int...
2013 OHSUG - Merging Multiple Drug Safety and Pharmacovigilance Databases int...2013 OHSUG - Merging Multiple Drug Safety and Pharmacovigilance Databases int...
2013 OHSUG - Merging Multiple Drug Safety and Pharmacovigilance Databases int...
 
2013 OHSUG - Integration of Argus and Other Products Using the E2B Interchange
2013 OHSUG - Integration of Argus and Other Products Using the E2B Interchange2013 OHSUG - Integration of Argus and Other Products Using the E2B Interchange
2013 OHSUG - Integration of Argus and Other Products Using the E2B Interchange
 
2013 OHSUG - Use Cases for Using the Program Type View in Oracle Life Science...
2013 OHSUG - Use Cases for Using the Program Type View in Oracle Life Science...2013 OHSUG - Use Cases for Using the Program Type View in Oracle Life Science...
2013 OHSUG - Use Cases for Using the Program Type View in Oracle Life Science...
 
2013 OHSUG - Facilitating Pharmacovigilance Globalization with Process Reengi...
2013 OHSUG - Facilitating Pharmacovigilance Globalization with Process Reengi...2013 OHSUG - Facilitating Pharmacovigilance Globalization with Process Reengi...
2013 OHSUG - Facilitating Pharmacovigilance Globalization with Process Reengi...
 
2013 OHSUG - Clinical Data Warehouse Implementation
2013 OHSUG - Clinical Data Warehouse Implementation2013 OHSUG - Clinical Data Warehouse Implementation
2013 OHSUG - Clinical Data Warehouse Implementation
 

Dernier

Annual General Meeting Presentation Slides
Annual General Meeting Presentation SlidesAnnual General Meeting Presentation Slides
Annual General Meeting Presentation SlidesKeppelCorporation
 
8447779800, Low rate Call girls in Tughlakabad Delhi NCR
8447779800, Low rate Call girls in Tughlakabad Delhi NCR8447779800, Low rate Call girls in Tughlakabad Delhi NCR
8447779800, Low rate Call girls in Tughlakabad Delhi NCRashishs7044
 
Innovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdfInnovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdfrichard876048
 
Organizational Structure Running A Successful Business
Organizational Structure Running A Successful BusinessOrganizational Structure Running A Successful Business
Organizational Structure Running A Successful BusinessSeta Wicaksana
 
Traction part 2 - EOS Model JAX Bridges.
Traction part 2 - EOS Model JAX Bridges.Traction part 2 - EOS Model JAX Bridges.
Traction part 2 - EOS Model JAX Bridges.Anamaria Contreras
 
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCRashishs7044
 
Financial-Statement-Analysis-of-Coca-cola-Company.pptx
Financial-Statement-Analysis-of-Coca-cola-Company.pptxFinancial-Statement-Analysis-of-Coca-cola-Company.pptx
Financial-Statement-Analysis-of-Coca-cola-Company.pptxsaniyaimamuddin
 
Church Building Grants To Assist With New Construction, Additions, And Restor...
Church Building Grants To Assist With New Construction, Additions, And Restor...Church Building Grants To Assist With New Construction, Additions, And Restor...
Church Building Grants To Assist With New Construction, Additions, And Restor...Americas Got Grants
 
Darshan Hiranandani [News About Next CEO].pdf
Darshan Hiranandani [News About Next CEO].pdfDarshan Hiranandani [News About Next CEO].pdf
Darshan Hiranandani [News About Next CEO].pdfShashank Mehta
 
1911 Gold Corporate Presentation Apr 2024.pdf
1911 Gold Corporate Presentation Apr 2024.pdf1911 Gold Corporate Presentation Apr 2024.pdf
1911 Gold Corporate Presentation Apr 2024.pdfShaun Heinrichs
 
8447779800, Low rate Call girls in Saket Delhi NCR
8447779800, Low rate Call girls in Saket Delhi NCR8447779800, Low rate Call girls in Saket Delhi NCR
8447779800, Low rate Call girls in Saket Delhi NCRashishs7044
 
Entrepreneurship lessons in Philippines
Entrepreneurship lessons in  PhilippinesEntrepreneurship lessons in  Philippines
Entrepreneurship lessons in PhilippinesDavidSamuel525586
 
Cybersecurity Awareness Training Presentation v2024.03
Cybersecurity Awareness Training Presentation v2024.03Cybersecurity Awareness Training Presentation v2024.03
Cybersecurity Awareness Training Presentation v2024.03DallasHaselhorst
 
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCRashishs7044
 
APRIL2024_UKRAINE_xml_0000000000000 .pdf
APRIL2024_UKRAINE_xml_0000000000000 .pdfAPRIL2024_UKRAINE_xml_0000000000000 .pdf
APRIL2024_UKRAINE_xml_0000000000000 .pdfRbc Rbcua
 
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCRashishs7044
 
NewBase 19 April 2024 Energy News issue - 1717 by Khaled Al Awadi.pdf
NewBase  19 April  2024  Energy News issue - 1717 by Khaled Al Awadi.pdfNewBase  19 April  2024  Energy News issue - 1717 by Khaled Al Awadi.pdf
NewBase 19 April 2024 Energy News issue - 1717 by Khaled Al Awadi.pdfKhaled Al Awadi
 
Independent Call Girls Andheri Nightlaila 9967584737
Independent Call Girls Andheri Nightlaila 9967584737Independent Call Girls Andheri Nightlaila 9967584737
Independent Call Girls Andheri Nightlaila 9967584737Riya Pathan
 
Buy gmail accounts.pdf Buy Old Gmail Accounts
Buy gmail accounts.pdf Buy Old Gmail AccountsBuy gmail accounts.pdf Buy Old Gmail Accounts
Buy gmail accounts.pdf Buy Old Gmail AccountsBuy Verified Accounts
 
PSCC - Capability Statement Presentation
PSCC - Capability Statement PresentationPSCC - Capability Statement Presentation
PSCC - Capability Statement PresentationAnamaria Contreras
 

Dernier (20)

Annual General Meeting Presentation Slides
Annual General Meeting Presentation SlidesAnnual General Meeting Presentation Slides
Annual General Meeting Presentation Slides
 
8447779800, Low rate Call girls in Tughlakabad Delhi NCR
8447779800, Low rate Call girls in Tughlakabad Delhi NCR8447779800, Low rate Call girls in Tughlakabad Delhi NCR
8447779800, Low rate Call girls in Tughlakabad Delhi NCR
 
Innovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdfInnovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdf
 
Organizational Structure Running A Successful Business
Organizational Structure Running A Successful BusinessOrganizational Structure Running A Successful Business
Organizational Structure Running A Successful Business
 
Traction part 2 - EOS Model JAX Bridges.
Traction part 2 - EOS Model JAX Bridges.Traction part 2 - EOS Model JAX Bridges.
Traction part 2 - EOS Model JAX Bridges.
 
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
 
Financial-Statement-Analysis-of-Coca-cola-Company.pptx
Financial-Statement-Analysis-of-Coca-cola-Company.pptxFinancial-Statement-Analysis-of-Coca-cola-Company.pptx
Financial-Statement-Analysis-of-Coca-cola-Company.pptx
 
Church Building Grants To Assist With New Construction, Additions, And Restor...
Church Building Grants To Assist With New Construction, Additions, And Restor...Church Building Grants To Assist With New Construction, Additions, And Restor...
Church Building Grants To Assist With New Construction, Additions, And Restor...
 
Darshan Hiranandani [News About Next CEO].pdf
Darshan Hiranandani [News About Next CEO].pdfDarshan Hiranandani [News About Next CEO].pdf
Darshan Hiranandani [News About Next CEO].pdf
 
1911 Gold Corporate Presentation Apr 2024.pdf
1911 Gold Corporate Presentation Apr 2024.pdf1911 Gold Corporate Presentation Apr 2024.pdf
1911 Gold Corporate Presentation Apr 2024.pdf
 
8447779800, Low rate Call girls in Saket Delhi NCR
8447779800, Low rate Call girls in Saket Delhi NCR8447779800, Low rate Call girls in Saket Delhi NCR
8447779800, Low rate Call girls in Saket Delhi NCR
 
Entrepreneurship lessons in Philippines
Entrepreneurship lessons in  PhilippinesEntrepreneurship lessons in  Philippines
Entrepreneurship lessons in Philippines
 
Cybersecurity Awareness Training Presentation v2024.03
Cybersecurity Awareness Training Presentation v2024.03Cybersecurity Awareness Training Presentation v2024.03
Cybersecurity Awareness Training Presentation v2024.03
 
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR
 
APRIL2024_UKRAINE_xml_0000000000000 .pdf
APRIL2024_UKRAINE_xml_0000000000000 .pdfAPRIL2024_UKRAINE_xml_0000000000000 .pdf
APRIL2024_UKRAINE_xml_0000000000000 .pdf
 
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
 
NewBase 19 April 2024 Energy News issue - 1717 by Khaled Al Awadi.pdf
NewBase  19 April  2024  Energy News issue - 1717 by Khaled Al Awadi.pdfNewBase  19 April  2024  Energy News issue - 1717 by Khaled Al Awadi.pdf
NewBase 19 April 2024 Energy News issue - 1717 by Khaled Al Awadi.pdf
 
Independent Call Girls Andheri Nightlaila 9967584737
Independent Call Girls Andheri Nightlaila 9967584737Independent Call Girls Andheri Nightlaila 9967584737
Independent Call Girls Andheri Nightlaila 9967584737
 
Buy gmail accounts.pdf Buy Old Gmail Accounts
Buy gmail accounts.pdf Buy Old Gmail AccountsBuy gmail accounts.pdf Buy Old Gmail Accounts
Buy gmail accounts.pdf Buy Old Gmail Accounts
 
PSCC - Capability Statement Presentation
PSCC - Capability Statement PresentationPSCC - Capability Statement Presentation
PSCC - Capability Statement Presentation
 

Flexible Study Design in Oracle Clinical and Remote Data Capture 4.6

  • 1. Working with Oracle Clinical/RDC: Flexible Study Design Steven Rifkin
  • 2. Welcome and Introduction Steven Rifkin Chief Application Expert • 15+ years of experience with Oracle Clinical, TMS and RDC; doing Database Design, Study Conduct and custom programming
  • 3. Today’s Agenda Time Topic 10:00-10:05 Welcome and Introduction 10:05-10:10 Who, What and Why? 10:10-10:30 Flexible Study Design Discussion and Demonstrations 10:30-10:45 Flexible Study Setup 10:45-10:55 Q&A 10:55-11:00 Wrap-up and Contact Information
  • 4. Who, What and Why? • Who is the intended audience? – Current OC/RDC users contemplating an upgrade to version 4.6 – New users of OC/RDC 4.6 who want to learn more about flexible study design – Non-OC/RDC users evaluating the features of the application who perhaps previously reviewed an earlier OC/RDC version
  • 5. Who, What and Why? • What features are we examining today? – Demonstrate a flexible study showing ability to enable or disable entire forms or visits based on data responses – Setting up a Flexible Study via an Enhanced DCI Book
  • 6. Who, What and Why? • Why are these features important? – Organizations need the ability to create a study schedule which is flexible for more complex clinical trials – Especially important when the sites will perform the entry in an EDC system so that users are presented only with the forms/visits they need
  • 7. Flexible Study Design … • Prior to Release 4.6, Oracle Clinical required strict sequential navigation through a set of Clinical Planned Events in a DCI book • Some trials require complex (or flexible) studies with multiple treatment arms with different patient groups receiving different assessments – Common for Oncology trials
  • 8. Flexible Study Design • Release 4.6 allows multiple pathways to be defined in a single DCI Book using conditional logic based on data for a specific patient – Logic will make a new set of visits and CRFs expected for the patient • The RDC Onsite interface now has a dynamic display of newly expected visit and CRF data as patient data is entered
  • 9. Example Study Screening Completion A:Cycle 2 A:Cycle 3A:Cycle 1 B:Cycle 2B:Cycle 1 Logs Treatment 1 Treatment 2 Treatment 3 Interim Treatment 1 Treatment 2 Treatment 3 Interim Treatment 4 Arm A Arm B
  • 10. Rules for Example Study 1. Until any data for Demography form is entered, only the Screening Visit is expected; after demography data, the Completion and AE Log visits are expected 2. The Enrollment CRF during the screening Visit will determine and schedule the Cycle 1 visits in either Arm A or Arm B 3. Response to a question during Interim Visit in a cycle with schedule next cycle or end the study for subject 4. If treatment not given during any treatment visit, subject will leave the study 5. If treatment is given, a new expected form is added for the visit
  • 11. Example Study: Rule 1 Screening Completion A:Cycle 2 A:Cycle 3A:Cycle 1 B:Cycle 2B:Cycle 1 Logs Treatment 1 Treatment 2 Treatment 3 Interim Treatment 1 Treatment 2 Treatment 3 Interim Treatment 4 Arm A Arm B Only the Screening Visit is expected until data entered on the Demography form. Demog entry will enable the Completion Visit and the AE Log
  • 13. Example Study: Rule 2 Screening Completion A:Cycle 2 A:Cycle 3A:Cycle 1 B:Cycle 2B:Cycle 1 Logs Treatment 1 Treatment 2 Treatment 3 Interim Treatment 1 Treatment 2 Treatment 3 Interim Treatment 4 Arm A Arm B Enrollment CRF specifies if Patient is in Arm A or Arm B and schedules cycle 1 treatments
  • 15. Example Study: Rule 3 Screening Completion A:Cycle 2 A:Cycle 3A:Cycle 1 B:Cycle 2B:Cycle 1 Logs Treatment 1 Treatment 2 Treatment 3 Interim Treatment 1 Treatment 2 Treatment 3 Interim Treatment 4 Arm A Arm B YES to “continue to next cycle” in any Interim Visit will schedule the next Treatment Cycle NO to “continue to next cycle” in any Interim Visit bypass remaining cycles
  • 17. Example Study: Rule 4 Screening Completion A:Cycle 2 A:Cycle 3A:Cycle 1 B:Cycle 2B:Cycle 1 Logs Treatment 1 Treatment 2 Treatment 3 Interim Treatment 1 Treatment 2 Treatment 3 Interim Treatment 4 Arm A Arm B NO to “give treatment” in any treatment will bypass remaining visits and cycles
  • 19. Example Study: Rule 5 YES to “should drug be given” in any treatment will schedule a new form to be completed at the visit HEMATOLOGY FORM Should Drug be given? Yes INFUSION FORM
  • 21. Setup of a Flexible Study 1. Identify the Study as Flexible during initial study setup to set the Clinical Study State 2. Define Intervals and Clinical Planned Events for the study 3. Set up “Enhanced” DCI Book with DCI Book Rules
  • 22. Creating a Flexible Study Conduct  Security  Clinical Study States
  • 23. Intervals • An Interval is a time span in which there are one or more visits (Clinical Planned Events) • Types of Intervals – Phase – Periods – Sub-periods Modeling the study will involve placing visits in specific Intervals • Need to plan since visits in an interval will be enabled by logic in Flex Study Design Phase Period Sub-Period Intervals
  • 24. Modeling Intervals Periods Treatment Phase Completion Phase Screening Phase Logs Phases Sub-periods Arm A Arm B A: Cycle 1 A: Cycle 3A: Cycle 2 B: Cycle 1 B: Cycle 2 indicate intervals where visits (CPEs) will be placed Each Interval must have a unique name
  • 25. Defining Intervals Intervals are defined from the Easy Study Design Screen Design  Studies  Easy Study Design
  • 26. Defining Clinical Planned Events … • Each Clinical Planned Event used in your study must be defined and associated with an Interval (Phase, Period or Sub-period) • Each CPE in the study must have a unique name – use a shorthand to indicate parent phase, period and sub-period – Treatment 1 visit is defined in multiple intervals • Visit for Treatment Phase, Arm A, Cycle 1 named AC1 TREATMENT 1 • Visit for Treatment Phase, Arm A, Cycle 2 named AC2 TREATMENT 1 • Visit for Treatment Phase, Arm B, Cycle 1 named BC1 TREATMENT 1 • Visit No. field reflects the sequence in the schedule and will not reflect the actual sequence of events for a patient • Duration fields are required but have no effect on the flexible study definition
  • 27. Enhanced DCI Books … • Function for Enhanced DCI Books has four sections – Navigator: Display screen listing the visits defined for the study and the interval to which each is assigned – Constraints: Limit the unplanned use of specific DCIs (no change from earlier versions) – Interval Rules: Define when an interval and its associated visits and DCIs will become expected – DCI Rules: Define when a specific DCI becomes expected in a visit or over all visits 27
  • 28. Enhanced DCI Books Definition  DCIs  Enhanced DCI Books Buttons will be disabled for non-flexible studies
  • 29. Enhanced DCI Books: Navigator … Definition  DCIs  Enhanced DCI Books, [Navigator] This column will be blank for non-flexible studies Select a Visit and click [DCI Book Pages for CPE] to define which DCIs are expected for that Visit Counts will update dynamically as DCIs are added to Visits and Rules defined CPE and Intervals are pre-populated with Events for the Study
  • 30. Enhanced DCI Books: Navigator … Definition  DCIs  Enhanced DCI Books, [Navigator], [DCI Book Pages for CPE] Enter (or select with LOV) a DCI that may be expected at this Visit Use the buttons to change the Visit to which DCIs will be assigned
  • 31. Enhanced DCI Books: Rules • Book Rules are available only for Flexible Studies • Rules apply to all patients to which the book is assigned • Interval Rules enable an interval and the visits within the intervals • DCI Rules enable a specific DCI – DCI within the current visit or – DCI across all visits in which the DCI is defined • Rules determine “expectedness”
  • 32. Enhanced DCI Books: Interval Rules • All Intervals are considered enabled unless a target of an Interval Rule • Interval Rules are specified for a specific DCI – will apply to all visits where the DCI is entered • Triggers at a DCI determine if an interval is enabled – Trigger Conditions • Trigger an interval when any data is entered in the DCI • Trigger an interval when there is a specified response to a question – Trigger Actions • Enable one or more named target intervals • Enable Next Interval • Bypass to a specified target interval
  • 33. Enhanced DCI Books: Rules Prior to definition of any Book Rules all DCIs in all CPEs in all intervals will appear in the RDC surround
  • 34. Enhanced DCI Books: Interval Rules … Definitions  DCIs  Enhanced DCI Books, [Interval Rules] RULE: Enable the Completion and Logs Intervals if any data is entered on Demography
  • 35. Enhanced DCI Books: Interval Rules … Before Demography Entered: Completion and Logs Intervals do not appear -- they are now Targets of Rules
  • 36. Enhanced DCI Books: Interval Rules … After Demography Entered: Completion and Logs Intervals appear -- the Interval Rule enables them Treatment intervals still appear because these are not yet targets of an interval rule!
  • 37. Enhanced DCI Books: Interval Rules … Definitions  DCIs  Enhanced DCI Books, [Interval Rules] RULE: enable the “A Cycle 1” Interval or the “B Cycle 1” Interval dependent on the Arm assigned on Enrollment DCI
  • 38. Enhanced DCI Books: Interval Rules … Before Enrollment DCI is completed, no visits in either the “A Cycle 1” Interval or the “B Cycle 1” Interval will be present because both intervals are now targets
  • 39. Enhanced DCI Books: Interval Rules … When Enrollment DCI is completed, the visits in either the “A Cycle 1” Interval or the “B Cycle 1” Interval will be added as enabled Enrolled in A Arm
  • 40. Enhanced DCI Books: Interval Rules … RULE: At last (INTERIM) visit for any cycle, if response to the NEXT_CYCLE_YN question is NO, bypass to the COMPLETION Interval; if response is YES, then enable the next sequential interval
  • 41. Enhanced DCI Books: Interval Rules … Without DEMOGRAPHY, only Screening Interval is enabled since use of [Next Interval] at the end of all cycles makes each treatment cycle a target of a rule
  • 42. Enhanced DCI Books: Interval Rules … With DEMOGRAPHY, Completion and Logs Intervals are enabled
  • 43. Enhanced DCI Books: Interval Rules … If Enrolled in Arm A, Cycle 1 for Arm A enabled
  • 44. Enhanced DCI Books: Interval Rules … At INTERIM Visit for Arm A Cycle 1, specify YES to continue to next cycle -- and Arm A Cycle 2 Visits are enabled
  • 45. Enhanced DCI Books: Interval Rules … At INTERIM Visit for Arm A Cycle 1, specify NO to continue to next cycle -- and Arm A Cycle 2 Visits are not enabled: bypassed other cycles
  • 46. Enhanced DCI Books: Interval Rules … At INTERIM Visit for Cycle 2, specify YES to continue to next cycle -- and Arm A Cycle 3 Visits are enabled
  • 47. Enhanced DCI Books: Interval Rules At AC1 Treatment 2, Dose was not given. Only Visits in the Completion and Logs Intervals are enabled; Visits after the current visit in the current interval are disabled!
  • 48. Enhanced DCI Books: DCI Rules … • Within an Interval, rules can be defined to enable specific DCIs in the visit or across all visits which contain that DCI – Only DCIs which contain one or more questions associated with a DVG can be have DCI rules
  • 49. Enhanced DCI Books: DCI Rules … RULE: At a Treatment Visit, if the Dose is given (GIVE_DOSE_YN=YES) then an infusion form must be made “expected” in that visit
  • 50. Enhanced DCI Books: DCI Rules Before GIVE_DOSE_YN was completed, no INFUSION form expected at visit After GIVE_DOSE_YN was completed, an INFUSION form is expected at visit!
  • 51. Q&A
  • 52. Closing Thank you for attending! This webinar will be posted on www.biopharm.com within 24 hours Contact BioPharm United States: +1 877 654 0033 United Kingdom: +44 (0) 1865 910200 Email Address: info@biopharm.com